EMA opens registration for it's sixth annual workshop on pediatric drug research and development.
The European Medicines Agency (EMA) has begun registration for its sixth workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA). The workshop will take place at EMA’s headquarters in London on June 26-27, 2014. The workshop, which aims to strengthen communication between stakeholders, will update participants from all aspects of the industry on “Enpr-EMA’s efforts to foster high-quality paediatric drug research and to contribute to the ongoing development of research and clinical trials in the area of paediatric medicine.”
Enpr-EMA, which is comprised by a network of research networks, investigators, and centers with expertise in performing clinical studies in children, fosters ethical research on the quality, safety and efficacy of medicines for use in children; helps recruit patients for clinical trials, and creates collaboration between networks.
Workshop registration forms can be found on EMA’s website) and should be submitted to enprema@ema.europa.eu.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.